Digital Content 
NEWS #PharmaBuzz
11 Dec 2024
// PRESS RELEASE
https://www.pfizer.com/news/press-release/press-release-detail/arvinas-and-pfizer-announce-initial-phase-1b-data-tactive-u
25 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/25/2987123/0/en/Arvinas-Announces-Upcoming-Vepdegestrant-Poster-Presentations-at-the-2024-San-Antonio-Breast-Cancer-Symposium.html
18 May 2024
// INDINPHARMAPOST
https://www.indianpharmapost.com/diagnostic-center/arvinas-and-pfizer-announce-updated-clinical-data-from-phase-1b-trial-of-vepdegestrant-in-combination-with-palbociclib-15660
16 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/16/2883219/0/en/Arvinas-and-Pfizer-Announce-Updated-Clinical-Data-from-Phase-1b-Trial-of-Vepdegestrant-in-Combination-with-Palbociclib-IBRANCE.html
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2879260/0/en/Arvinas-Announces-Upcoming-Vepdegestrant-Poster-Presentations-at-the-2024-European-Society-for-Medical-Oncology-ESMO-Breast-Cancer-Annual-Congress.html
14 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/14/2829038/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer.html
LOOKING FOR A SUPPLIER?
Share